161 related articles for article (PubMed ID: 29301655)
1. Intrathecal antibody responses to GalC in Guillain-Barré syndrome triggered by Mycoplasma pneumoniae.
Meyer Sauteur PM; Huizinga R; Tio-Gillen AP; Drenthen J; Unger WWJ; Jacobs E; van Rossum AMC; Jacobs BC
J Neuroimmunol; 2018 Jan; 314():13-16. PubMed ID: 29301655
[TBL] [Abstract][Full Text] [Related]
2. Mycoplasma pneumoniae triggering the Guillain-Barré syndrome: A case-control study.
Meyer Sauteur PM; Huizinga R; Tio-Gillen AP; Roodbol J; Hoogenboezem T; Jacobs E; van Rijn M; van der Eijk AA; Vink C; de Wit MC; van Rossum AM; Jacobs BC
Ann Neurol; 2016 Oct; 80(4):566-80. PubMed ID: 27490360
[TBL] [Abstract][Full Text] [Related]
3. Cross-reactive anti-galactocerebroside antibodies and Mycoplasma pneumoniae infections in Guillain-Barré syndrome.
Ang CW; Tio-Gillen AP; Groen J; Herbrink P; Jacobs BC; Van Koningsveld R; Osterhaus AD; Van der Meché FG; van Doorn PA
J Neuroimmunol; 2002 Sep; 130(1-2):179-83. PubMed ID: 12225900
[TBL] [Abstract][Full Text] [Related]
4. Acute motor axonal neuropathy after Mycoplasma infection: Evidence of molecular mimicry.
Susuki K; Odaka M; Mori M; Hirata K; Yuki N
Neurology; 2004 Mar; 62(6):949-56. PubMed ID: 15037698
[TBL] [Abstract][Full Text] [Related]
5. Immunoadsorption therapy for a child with Guillain-Barre syndrome subsequent to Mycoplasma infection: a case study.
Arakawa H; Yuhara Y; Todokoro M; Kato M; Mochizuki H; Tokuyama K; Kunimoto F; Morikawa A
Brain Dev; 2005 Sep; 27(6):431-3. PubMed ID: 16122631
[TBL] [Abstract][Full Text] [Related]
6. Clinical features in Guillain-Barré syndrome with anti-Gal-C antibody.
Samukawa M; Hamada Y; Kuwahara M; Takada K; Hirano M; Mitsui Y; Sonoo M; Kusunoki S;
J Neurol Sci; 2014 Feb; 337(1-2):55-60. PubMed ID: 24289889
[TBL] [Abstract][Full Text] [Related]
7. Anti-Gal-C antibodies in GBS subsequent to mycoplasma infection: evidence of molecular mimicry.
Kusunoki S; Shiina M; Kanazawa I
Neurology; 2001 Aug; 57(4):736-8. PubMed ID: 11524496
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of anti-heat shock protein antibodies in cerebrospinal fluids of patients with Guillain-Barré syndrome.
Yonekura K; Yokota S; Tanaka S; Kubota H; Fujii N; Matsumoto H; Chiba S
J Neuroimmunol; 2004 Nov; 156(1-2):204-9. PubMed ID: 15465612
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal anti-alphaB-crystallin IgG antibody responses: potential inflammatory markers in Guillain-Barré syndrome.
Wanschitz J; Ehling R; Löscher WN; Künz B; Deisenhammer F; Kuhle J; Budka H; Reindl M; Berger T
J Neurol; 2008 Jun; 255(6):917-24. PubMed ID: 18712293
[TBL] [Abstract][Full Text] [Related]
10. Antibody responses to GalC in severe and complicated childhood Guillain-Barré syndrome.
Meyer Sauteur PM; Huizinga R; Tio-Gillen AP; de Wit MY; Unger WWJ; Berger C; van Rossum AMC; Jacobs BC
J Peripher Nerv Syst; 2018 Mar; 23(1):67-69. PubMed ID: 29119633
[No Abstract] [Full Text] [Related]
11. The presence of Mycoplasma pneumoniae infection and GM1 ganglioside antibodies in Guillain-Barré syndrome.
Sharma MB; Chaudhry R; Tabassum I; Ahmed NH; Sahu JK; Dhawan B; Kalra V
J Infect Dev Ctries; 2011 Jul; 5(6):459-64. PubMed ID: 21727645
[TBL] [Abstract][Full Text] [Related]
12. A 3-year-old boy with Guillain-Barré syndrome and encephalitis associated with Mycoplasma pneumoniae infection.
Hanzawa F; Fuchigami T; Ishii W; Nakajima S; Kawamura Y; Endo A; Arakawa C; Kohira R; Fujita Y; Takahashi S
J Infect Chemother; 2014 Feb; 20(2):134-8. PubMed ID: 24462436
[TBL] [Abstract][Full Text] [Related]
13. Guillain-Barré syndrome and optic neuritis after Mycoplasma pneumoniae infection.
Matsunaga M; Kodama Y; Maruyama S; Miyazono A; Seki S; Tanabe T; Yoshimura M; Nishi J; Kawano Y
Brain Dev; 2018 May; 40(5):439-442. PubMed ID: 29429558
[TBL] [Abstract][Full Text] [Related]
14. Anti-galactocerebroside testing in Mycoplasma pneumoniae-associated encephalitis.
Christie LJ; Honarmand S; Yagi S; Ruiz S; Glaser CA
J Neuroimmunol; 2007 Sep; 189(1-2):129-31. PubMed ID: 17651816
[TBL] [Abstract][Full Text] [Related]
15. [Guillain-Barré syndrome and Mycoplasma pneumoniae infection].
Vinzio S; Andres E; Goichot B; Schlienger JL
Ann Med Interne (Paris); 2000 Jun; 151(4):309-10. PubMed ID: 10922961
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the neurological diseases associated with Mycoplasma pneumoniae infection and anti-glycolipid antibodies.
Kuwahara M; Samukawa M; Ikeda T; Morikawa M; Ueno R; Hamada Y; Kusunoki S
J Neurol; 2017 Mar; 264(3):467-475. PubMed ID: 28025664
[TBL] [Abstract][Full Text] [Related]
17. Anti-ganglioside antibodies and elevated CSF IgG levels in Guillain-Barré syndrome.
Matà S; Galli E; Amantini A; Pinto F; Sorbi S; Lolli F
Eur J Neurol; 2006 Feb; 13(2):153-60. PubMed ID: 16490046
[TBL] [Abstract][Full Text] [Related]
18. Severe childhood Guillain-Barré syndrome associated with Mycoplasma pneumoniae infection: a case series.
Meyer Sauteur PM; Roodbol J; Hackenberg A; de Wit MC; Vink C; Berger C; Jacobs E; van Rossum AM; Jacobs BC
J Peripher Nerv Syst; 2015 Jun; 20(2):72-8. PubMed ID: 26115201
[TBL] [Abstract][Full Text] [Related]
19. Nodal proteins are target antigens in Guillain-Barré syndrome.
Devaux JJ; Odaka M; Yuki N
J Peripher Nerv Syst; 2012 Mar; 17(1):62-71. PubMed ID: 22462667
[TBL] [Abstract][Full Text] [Related]
20. Higher frequencies of HLA DQB1*05:01 and anti-glycosphingolipid antibodies in a cluster of severe Guillain-Barré syndrome.
Schirmer L; Worthington V; Solloch U; Loleit V; Grummel V; Lakdawala N; Grant D; Wassmuth R; Schmidt AH; Gebhardt F; Andlauer TF; Sauter J; Berthele A; Lunn MP; Hemmer B
J Neurol; 2016 Oct; 263(10):2105-13. PubMed ID: 27485170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
